alexa Congenital Myasthenic Syndromes | Australia | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

  • Internaltional Conference
    Internal Medicine
    Revealing Advancements in Internal Medicine and Health Care
    May 21-22, 2018 Osaka, Japan
  • 7th International Conference on
    Clinical and Medical Case Reports
    Focusing the breakthroughs of case reports in Clinical & Medical Research
    June 01-02, 2018 Osaka, Japan
  • International Conference
    Exploring the innovation in Emergency & Acute Care Medicine
    August 22-23, 2018 Tokyo, Japan
  • 14th International Conference
    Clinical Gastroenterology and Hepatology
    Theme: Knowing the unknown and finer facets of Gastroenterology
    August 29-30, 2018 Toronto, Canada
  • World Conference
    New Technologies and Methodologies in Neurology ad Neuromuscular Disorders
    September 13-14, 2018 Frankfurt, Germany
  • 3rd International Conference on
    Internal Medicine and Hospital Medicine
    October 23-24, 2018 Toronto, Canada

Relevant Topics

Congenital Myasthenic Syndromes

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Congenital Myasthenic Syndromes

    Congenital myasthenic syndrome is a group of conditions characterized by muscle weakness (myasthenia) that worsens with physical exertion. The muscle weakness typically begins in early childhood but can also appear in adolescence or adulthood. Facial muscles, including muscles that control the eyelids, muscles that move the eyes, and muscles used for chewing and swallowing, are most commonly affected. However, any of the muscles used for movement (skeletal muscles) can be affected in this condition. Due to muscle weakness, affected infants may have feeding difficulties.

  • Congenital Myasthenic Syndromes

    Congenital myasthenic syndromes (CMSs) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more mechanisms. Specific diagnosis of a CMS is important as some medications that benefit one type of CMS can be detrimental in another type. In some CMSs, strong clinical clues point to a specific diagnosis.

  • Congenital Myasthenic Syndromes

    By identifying the genetic defects that cause CMS, MDA-funded scientists have improved the diagnosis of CMS and discovered drugs that are effective against it. They’re pursuing better drug treatments, and eyeing techniques to fix or replace the underlying genetic defects by gene therapy. n the past, people with congenital myasthenic syndromes (CMS) were often told they had myasthenia gravis (MG) and were subjected to years of pointless immunosuppressive therapy.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings